Cardiff Oncology (CRDF) FY Conference January 18, 2023 01:30 PM ET Speaker0 All right. Good afternoon, everyone. Welcome to B. Riley Securities Oncology Conference and listening to our fireside chat. I'm Yuan Zhi, a healthcare equity research analyst at B. Riley Securities. Today, it's my great pleasure to have Mark Erlander, CEO of Cardiff Oncology. Thank you for joining us today. I want to focus today's discussion on your clinical trial of colorectal cancer and pancreatic cancer. But Mark, can you give us ...